Patents

  • Patent Number Year Symeres Authors Customer
    Methods and intermediates for the preparation of bile acid derivatives US11066437B2 2021 Frederik Ronald Leusink, Bartjan Koning, Thomas Hensel Intercept Pharmaceuticals

    Read more

  • Patent Number Year Symeres Authors Customer
    Heterocyclic derivatives, pharmaceutical compositions and their use in the treatment or amelioration of cancer WO 2021/064142 A1 2021 Johan Veerman, Rutger Folmer, Martijn Eerland, Koen Hekking Tolremo

    Read more

  • Patent Number Year Symeres Authors Customer
    Inhibitors of dual specificity tyrosine phosphorylation regulated kinase 1b WO 2021/064141 A1 2021 Koen Hekking, Rutger Folmer Tolremo

    Read more

  • Patent Number Year Symeres Authors Customer
    Progranulin Modulators and methods of using the same WO 2021/127303 2021 Jean-Paul Seerden, Wim Zonneveld, Roel Bell Arkuda Therapeutics

    Read more

  • Patent Number Year Symeres Authors Customer
    Synthesis of labeled imidazo[1,2-a]pyrimidines (Exemplify) EP 3966215 A1 2020 William Nack, Paul O’Shea Hoffmann La Roche

    Read more

  • Patent Number Year Symeres Authors Customer
    Regio-selective synthesis of imidazo[1,2-a]pyrimidines (Exemplify) WO 2020/227576 A1 2020 William Nack, Paul O’Shea Genentech

    Read more

  • Patent Number Year Symeres Authors Customer
    Methods for making thiszolylpyrazole carboxylic acids and intermediates therefor (Exemplify) WO 2020/243582 A1 2020 Paul O’Shea Bantam Pharmaceutical

    Read more

  • Patent Number Year Symeres Authors Customer
    Pharmaceutical formulations containing p2y14 antagonists (Exemplify) WO 2020/214510 A1 2020 Yadan Chen Kantum Pharma

    Read more

  • Patent Number Year Symeres Authors Customer
    Heterocyclic derivatives, pharmaceutical compositions and their use in the treatment, amelioration or prevention of cancer WO 2020/127200 A1 2020 Johan Veerman, Rutger Folmer Tolremo

    Read more

  • Patent Number Year Symeres Authors Customer
    Novel phenyl and pyridyl ureas active against the hepatitis b virus (hbv) WO 2020/221816 2020 Jasper Springer AiCuris

    Read more

Feel free to contact us!

Curious to know more about what can we do for you? Get in touch and let’s start a conversation.

Contact us